{"id":3586,"date":"2025-04-08T15:29:57","date_gmt":"2025-04-08T12:29:57","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=3586"},"modified":"2025-04-08T15:29:58","modified_gmt":"2025-04-08T12:29:58","slug":"new-drug-submission-for-agamree-vamorolone-accepted-for-priority-review-by-health-canada-for-the-treatment-of-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/ar\/new-drug-submission-for-agamree-vamorolone-accepted-for-priority-review-by-health-canada-for-the-treatment-of-duchenne-muscular-dystrophy\/","title":{"rendered":"\u062a\u0645 \u0642\u0628\u0648\u0644 \u0637\u0644\u0628 \u062f\u0648\u0627\u0621 \u062c\u062f\u064a\u062f \u0644\u0640 AGAMREE (vamorolone) \u0644\u0644\u0645\u0631\u0627\u062c\u0639\u0629 \u0627\u0644\u0623\u0648\u0644\u064a\u0629 \u0645\u0646 \u0642\u0628\u0644 \u0648\u0632\u0627\u0631\u0629 \u0627\u0644\u0635\u062d\u0629 \u0627\u0644\u0643\u0646\u062f\u064a\u0629 \u0644\u0639\u0644\u0627\u062c \u0636\u0645\u0648\u0631 \u0627\u0644\u0639\u0636\u0644\u0627\u062a \u062f\u0648\u0634\u064a\u0646"},"content":{"rendered":"<p class=\"wp-block-paragraph\">\u0623\u0639\u0644\u0646\u062a \u0645\u0646\u0638\u0645\u0629 Catalyst Pharmaceuticals \u0623\u0646 \u0648\u0632\u0627\u0631\u0629 \u0627\u0644\u0635\u062d\u0629 \u0627\u0644\u0643\u0646\u062f\u064a\u0629 \u0642\u062f \u0642\u0628\u0644\u062a \u0637\u0644\u0628\u0647\u0627 \u0627\u0644\u062e\u0627\u0635 \u0628\u062f\u0648\u0627\u0621 \u062c\u062f\u064a\u062f (NDS) \u0644\u062f\u0648\u0627\u0621 AGAMREE (vamorolone) \u0645\u0639 \u0623\u0648\u0644\u0648\u064a\u0629 \u0627\u0644\u0645\u0631\u0627\u062c\u0639\u0629 \u0644\u0639\u0644\u0627\u062c \u0636\u0645\u0648\u0631 \u0627\u0644\u0639\u0636\u0644\u0627\u062a \u062f\u0648\u0634\u064a\u0646 (DMD). \u0641\u064a \u062d\u0627\u0644 \u0627\u0644\u0645\u0648\u0627\u0641\u0642\u0629\u060c \u0633\u064a\u0635\u0628\u062d AGAMREE \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0623\u0648\u0644 \u0648\u0627\u0644\u0648\u062d\u064a\u062f \u0627\u0644\u0645\u0639\u062a\u0645\u062f \u0645\u0646 \u0648\u0632\u0627\u0631\u0629 \u0627\u0644\u0635\u062d\u0629 \u0627\u0644\u0643\u0646\u062f\u064a\u0629 \u0644\u0636\u0645\u0648\u0631 \u0627\u0644\u0639\u0636\u0644\u0627\u062a \u062f\u0648\u0634\u064a\u0646\u060c \u0645\u0639 \u0625\u0645\u0643\u0627\u0646\u064a\u0629 \u0627\u0644\u062d\u0635\u0648\u0644 \u0639\u0644\u0649 \u062a\u0631\u062e\u064a\u0635 \u0627\u0644\u062a\u0633\u0648\u064a\u0642 \u0628\u062d\u0644\u0648\u0644 \u0646\u0647\u0627\u064a\u0629 \u0639\u0627\u0645 2025.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u064a\u0623\u062a\u064a \u0647\u0630\u0627 \u0627\u0644\u062a\u0642\u062f\u064a\u0645 \u0628\u0639\u062f \u0645\u0648\u0627\u0641\u0642\u0627\u062a AGAMREE \u0641\u064a \u0627\u0644\u0648\u0644\u0627\u064a\u0627\u062a \u0627\u0644\u0645\u062a\u062d\u062f\u0629 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 (2023) \u0648\u0627\u0644\u0627\u062a\u062d\u0627\u062f \u0627\u0644\u0623\u0648\u0631\u0648\u0628\u064a (\u0623\u0648\u0627\u0626\u0644 2024). \u0648\u0648\u0641\u0642\u064b\u0627 \u0644\u0644\u0633\u062c\u0644 \u0627\u0644\u0643\u0646\u062f\u064a \u0644\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0639\u0635\u0628\u064a\u0629 \u0627\u0644\u0639\u0636\u0644\u064a\u0629\u060c \u064a\u064f\u0639\u0627\u0646\u064a \u0623\u0643\u062b\u0631 \u0645\u0646 800 \u0641\u062a\u0649 \u0648\u0634\u0627\u0628 \u0641\u064a \u0643\u0646\u062f\u0627 \u0645\u0646 \u0636\u0645\u0648\u0631 \u0627\u0644\u0639\u0636\u0644\u0627\u062a \u0627\u0644\u062f\u0648\u0634\u064a\u0646\u064a\u060c \u0648\u0647\u0648 \u0645\u0631\u0636 \u0646\u0627\u062f\u0631 \u064a\u064f\u0633\u0628\u0628 \u0636\u0639\u0641\u064b\u0627 \u0639\u0636\u0644\u064a\u064b\u0627 \u0628\u0633\u0628\u0628 \u0646\u0642\u0635 \u0628\u0631\u0648\u062a\u064a\u0646 \u0627\u0644\u062f\u064a\u0633\u062a\u0631\u0648\u0641\u064a\u0646.<a href=\"https:\/\/dmdwarrior.com\/ar\/what-is-agamree-vamorolone-what-is-agamree-used-for\/\" target=\"_blank\" data-type=\"post\" data-id=\"2333\" rel=\"noreferrer noopener\">\u0645\u0627 \u0647\u0648 \u0623\u062c\u0627\u0645\u0631\u064a\u061f<\/a>)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0634\u0645\u0644 \u062a\u0637\u0648\u064a\u0631 \u0627\u0644\u062f\u0648\u0627\u0621 \u062a\u062c\u0627\u0631\u0628 \u0633\u0631\u064a\u0631\u064a\u0629 \u0641\u064a \u062e\u0645\u0633\u0629 \u0645\u0648\u0627\u0642\u0639 \u0643\u0646\u062f\u064a\u0629\u060c \u0645\u0645\u0627 \u0633\u0627\u0647\u0645 \u0641\u064a \u0627\u0639\u062a\u0645\u0627\u062f\u0647 \u0639\u0627\u0644\u0645\u064a\u064b\u0627. \u0648\u0642\u062f \u0631\u062d\u0628\u062a \u0645\u0646\u0638\u0645\u0627\u062a \u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0645\u0631\u0636\u0649\u060c \u0628\u0645\u0627 \u0641\u064a \u0630\u0644\u0643 &quot;\u0647\u0632\u064a\u0645\u0629 \u062f\u0648\u0634\u064a\u0646 \u0643\u0646\u062f\u0627&quot; \u0648&quot;\u0627\u0644\u0636\u0645\u0648\u0631 \u0627\u0644\u0639\u0636\u0644\u064a \u0643\u0646\u062f\u0627&quot;\u060c \u0628\u0647\u0630\u0627 \u0627\u0644\u062a\u0637\u0648\u0631\u060c \u0645\u0633\u0644\u0637\u064a\u0646 \u0627\u0644\u0636\u0648\u0621 \u0639\u0644\u0649 \u0627\u0644\u0646\u0642\u0635 \u0627\u0644\u062d\u0627\u0644\u064a \u0641\u064a \u0627\u0644\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0645\u0639\u062a\u0645\u062f\u0629 \u0641\u064a \u0643\u0646\u062f\u0627.<\/p>","protected":false},"excerpt":{"rendered":"<p>Catalyst Pharmaceuticals has announced that Health Canada has accepted their New Drug Submission (NDS) for AGAMREE (vamorolone) with priority review status for treating Duchenne muscular dystrophy (DMD). If approved, AGAMREE would become the first and only Health Canada-approved therapy for DMD, with potential marketing authorization by the end of 2025. The submission follows AGAMREE&#8217;s approvals [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3588,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,171,43],"class_list":["post-3586","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-canada","tag-vamorolone"],"subtitle":"\u0645\u0646\u062d\u062a \u0648\u0632\u0627\u0631\u0629 \u0627\u0644\u0635\u062d\u0629 \u0627\u0644\u0643\u0646\u062f\u064a\u0629 \u0639\u0642\u0627\u0631 AGAMREE \u0645\u0631\u0627\u062c\u0639\u0629 \u0623\u0648\u0644\u064a\u0629 \u0648\u0642\u062f \u064a\u062a\u0645 \u0645\u0646\u062d\u0647 \u062a\u0631\u062e\u064a\u0635 \u0627\u0644\u062a\u0633\u0648\u064a\u0642 \u0642\u0628\u0644 \u0646\u0647\u0627\u064a\u0629 \u0639\u0627\u0645 2025.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/posts\/3586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/comments?post=3586"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/posts\/3586\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/media\/3588"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/media?parent=3586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/categories?post=3586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/tags?post=3586"}],"curies":[{"name":"\u0648\u0648\u0631\u062f\u0628\u0631\u064a\u0633","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}